Preclinical pharmacokinetics, biodistribution, radiation dosimetry and toxicity studies required for regulatory approval of a phase I clinical trial with In-111-CP04 in medullary thyroid carcinoma patients

Details

Database :

OAIster

Journal :

Maina , T , Konijnenberg , M , KolencPeitl , P , Garnuszek , P , Nock , B , Kaloudi , A , Kroselj , M , Zaletel , K , Maecke , H , Mansi , R , Erba , P , von Guggenberg , E , Hubalewska-Dydejczyk , A , Mikolajczak , R & Decristoforo , C 2016 , ' Preclinical pharmacokinetics, biodistribution, radiation dosimetry and toxicity studies required for regulatory approval of a phase I clinical trial with In-111-CP04 in medullary thyroid carcinoma patients ' , European Journal of Pharmaceutical Sciences , vol. 91 , pp. 236-242 .

Notes :

application/pdf, und

Publication Type :

Electronic Resource

Accession number :

edsoai.on1313620574

Document Type :

Electronic Resource